Ying Xu
Director Técnico/Científico/I+D en CANbridge Life Sciences Ltd. .
Origen de la red de primer grado Ying Xu.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ying Xu a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Brown University | College/University | Doctorate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
| Ecole Nationale des Ponts et Chaussées | College/University | Masters Business Admin | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
| Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
| Fudan University | College/University | Undergraduate Degree | |
| Central University of Finance & Economics | College/University | Graduate Degree | |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Director of Investments Private Equity Investor | |
| Peking University Health Science Center | College/University | Corporate Officer/Principal | |
| The BayHelix Group | Corporate Officer/Principal | ||
| University of California | College/University | Graduate Degree | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Michigan Medical School | College/University | Corporate Officer/Principal | |
| AMOY DIAGNOSTICS CO., LTD. | Medical Specialties | Director/Board Member | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
| CANbridge Consulting LLC | Founder | ||
| SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. | Medical Specialties | Director/Board Member | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. | Electronic Equipment/Instruments | Director/Board Member | |
Shanghai Xinghe Investment Management Co., Ltd.
 Shanghai Xinghe Investment Management Co., Ltd. Financial ConglomeratesFinance Shanghai Xinghe Investment Management Co., Ltd. provides investment services. The company was founded by Xue Cai Pan on February 25, 2011 and is headquartered in Shanghai, China. | Financial Conglomerates | Director/Board Member | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Zhejiang Boner Medical Investment Management Co., Ltd.
 Zhejiang Boner Medical Investment Management Co., Ltd. Hospital/Nursing ManagementHealth Services Zhejiang Boner Medical Investment Management Co. Ltd. engages in the provision of medical services and hospital provision. The company was founded on May 24, 2012 and is headquartered in Hangzhou, China. | Hospital/Nursing Management | Director/Board Member | |
Abbisko Therapeutics Co., Ltd.
 Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Director/Board Member | |
InSilico Medicine Hong Kong Ltd.
 InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong. | Information Technology Services | Director/Board Member | |
| MICROTECH MEDICAL (HANGZHOU) CO., LTD. | Electronic Equipment/Instruments | Director/Board Member | |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Zhuhai DL Biotech Co., Ltd.
 Zhuhai DL Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Zhuhai DL Biotech Co., Ltd. is a company based in Zhuhai, China that engages in research and development, production, and sales of microbiological diagnostic products and services. The Chinese company was founded in 2003 by Hua Qing Lin. | Miscellaneous Commercial Services | Director/Board Member | |
| Peking University School of Pharmaceutical Sciences | College/University | Undergraduate Degree | |
Shanghai Boendengte Technology Co., Ltd.
 Shanghai Boendengte Technology Co., Ltd. Packaged SoftwareTechnology Services Shanghai Boendengte Technology Co., Ltd. is a company that provides high-quality and cost-effective oral products through independent innovation. The company is based in Shanghai, China and was founded in 2009 by Fang Jun Tian. The Chinese company offers a range of oral equipment and consumables, including earl imaging products, simo dental microscopy, bomei star comprehensive treatment channel, corel correction products, iezplanting series, yirui m3 pipe series, and other products. The company is also the agent of the northern and Italian laser nationwide in the vdw of Germany. | Packaged Software | Director/Board Member | |
| JIANGSU YAHONG MEDITECH CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014. | Packaged Software | Director/Board Member | |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | President | |
| ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Qiming Weichuang Venture Capital Management Shanghai Co. Ltd. | Corporate Officer/Principal | ||
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Zion Pharma Ltd.
 Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Miscellaneous Commercial Services | Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| China Alliance For Rare Diseases | Corporate Officer/Principal | ||
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | ||
| MEDSCI HEALTHCARE HOLDINGS LIMITED | Medical/Nursing Services | Director/Board Member | |
| Shanghai Medsci Medtech Co. Ltd. | Director/Board Member | ||
| Kira Pharmaceuticals LLC | Director/Board Member | ||
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
| Shanghai Medical College of Fudan University | College/University | Undergraduate Degree |
Estadísticas
Internacional
| China | 30 |
| Estados Unidos | 19 |
| Francia | 2 |
| Hong-Kong | 2 |
| Islas Caimán | 2 |
Sectorial
| Health Technology | 18 |
| Consumer Services | 14 |
| Finance | 4 |
| Technology Services | 4 |
| Commercial Services | 4 |
Operativa
| Director/Board Member | 61 |
| Chairman | 12 |
| Corporate Officer/Principal | 11 |
| Independent Dir/Board Member | 9 |
| Undergraduate Degree | 6 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Xu Bo Hu | 34 |
| James Geraghty | 25 |
| Kan Chen | 17 |
| James Xue | 14 |
| Chun Sheng Song | 3 |
| Bo Dai | 2 |
| Wei Cao | 1 |
| Bing Liu | 1 |
- Bolsa de valores
- Insiders
- Ying Xu
- Conexiones Empresas
